Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 704854, 5 pages
http://dx.doi.org/10.1155/2014/704854
Research Article

Association between the −794 (CATT)5–8  MIF Gene Polymorphism and Susceptibility to Acute Coronary Syndrome in a Western Mexican Population

1Instituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950, Edificio Q, Primer Piso, Colonia Independencia, 44350 Guadalajara, JAL, Mexico
2Doctorado en Ciencias Biomédicas, Universidad de Guadalajara, Sierra Mojada 950, Colonia Independencia, 44350 Guadalajara, JAL, Mexico
3Doctorado en Genética Humana, Universidad de Guadalajara, Sierra Mojada 950, Colonia Independencia, 44350 Guadalajara, JAL, Mexico
4IMSS, Centro Medico Nacional de Occidente, Belisario Dominguez 1000, Colonia Independencia, 44340 Guadalajara, JAL, Mexico

Received 23 April 2014; Revised 30 May 2014; Accepted 3 June 2014; Published 3 July 2014

Academic Editor: Joseph Fomusi Ndisang

Copyright © 2014 Emmanuel Valdés-Alvarado et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Kumar, S. Kar, and W. P. Fay, “Thrombosis, physical activity, and acute coronary syndromes,” Journal of Applied Physiology, vol. 111, no. 2, pp. 599–605, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Panteghini, “Role and importance of biochemical markers in clinical cardiology,” European Heart Journal, vol. 25, no. 14, pp. 1187–1196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. K. A. A. Fox, J. Birkhead, R. Wilcox, C. Knight, and J. Barth, “British Cardiac Society Working Group on the definition of myocardial infarction,” Heart, vol. 90, no. 6, pp. 603–609, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Zernecke, J. Bernhagen, and C. Weber, “Macrophage migration inhibitory factor in cardiovascular disease,” Circulation, vol. 117, no. 12, pp. 1594–1602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Chen, M. Sakuma, A. C. Zago et al., “Evidence for a role of macrophage migration inhibitory factor in vascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 4, pp. 709–714, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Jednacz and L. Rutkowska-Sak, “Atherosclerosis in juvenile idiopathic arthritis,” Mediators of Inflammation, vol. 2012, Article ID 714732, 5 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Wildgruber, F. K. Swirski, and A. Zernecke, “Molecular imaging of inflammation in atherosclerosis,” Theranostics, vol. 3, no. 11, pp. 865–884, 2013. View at Google Scholar
  8. S.-A. Su, H. Ma, L. Shen, M.-X. Xiang, and J.-A. Wang, “Interleukin-17 and acute coronary syndrome,” Journal of Zhejiang University: Science B, vol. 14, no. 8, pp. 664–669, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Kahlenberg and M. J. Kaplan, “The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus,” Arthritis Research and Therapy, vol. 13, no. 1, article 203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Patel, K. M. Channon, and E. McNeill, “The downstream regulation of chemokine receptor signalling: implications for atherosclerosis,” Mediators of Inflammation, vol. 2013, Article ID 459520, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Leng and R. Bucala, “Insight into the biology of Macrophage Migration Inhibitory Factor (MIF) revealed by the cloning of its cell surface receptor,” Cell Research, vol. 16, no. 2, pp. 162–168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Cho and A. Baldan, “Quest for new biomarkers in atherosclerosis,” Missouri Medicine Journal, vol. 110, no. 4, pp. 325–330, 2013. View at Google Scholar
  13. M. Y. Lan, “Association between MIF gene polymorphisms and carotid artery atherosclerosis,” Biochemical and Biophysical Research Communications, vol. 435, no. 2, pp. 319–322, 2013. View at Publisher · View at Google Scholar
  14. R. Kleemann, S. Zadelaar, and T. Kooistra, “Cytokines and atherosclerosis: a comprehensive review of studies in mice,” Cardiovascular Research, vol. 79, no. 3, pp. 360–376, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. I. I. Müller, K. A. L. Müller, H. Schönleber et al., “Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response,” PLoS ONE, vol. 7, no. 6, Article ID e38376, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Llamas-Covarrubias, Y. Valle, R. Bucala et al., “Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis,” Cytokine, vol. 61, no. 3, pp. 759–765, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Llamas-Covarrubias, Y. Valle, RE. Navarro-Hernández et al., “Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis cours,” Rheumatology International, vol. 32, no. 8, pp. 2307–2311, 2012. View at Google Scholar
  18. R. Bucala, “MIF, MIF alleles, and prospects for therapeutic intervention in autoimmunity,” Journal of Clinical Immunology, vol. 33, supplement 1, pp. S72–S78, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. C. P. Cannon, R. G. Brindis, B. R. Chaitman et al., “2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards),” Critical Pathways in Cardiology, vol. 12, no. 2, pp. 65–105, 2013. View at Google Scholar
  20. S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, article 1215, 1988. View at Publisher · View at Google Scholar · View at Scopus
  21. T. R. D. J. Radstake, F. C. G. J. Sweep, P. Welsing et al., “Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor,” Arthritis & Rheumatism, vol. 52, no. 10, pp. 3020–3029, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Yayan, “Emerging families of biomarkers for coronary artery disease: inflammatory mediators,” Vascular Health and Risk Management, vol. 9, pp. 435–456, 2013. View at Google Scholar
  23. S. Ayoub, M. J. Hickey, and E. F. Morand, “Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis,” Nature Clinical Practice Rheumatology, vol. 4, no. 2, pp. 98–105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. D. A. White, L. Fang, W. Chan, E. F. Morand, H. Kiriazis, S. J. Duffy et al., “Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells,” PLoS ONE, vol. 8, no. 10, Article ID e76206, 2013. View at Google Scholar
  25. A. Sreih, R. Ezzeddine, L. Leng et al., “Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 63, no. 12, pp. 3942–3951, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. G. A. Awandare, J. J. Martinson, T. Were et al., “MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia,” Journal of Infectious Diseases, vol. 200, no. 4, pp. 629–637, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. L. E. Lehmann, S. Schroeder, W. Hartmann et al., “A single nucleotide polymorphism of macrophage migration inhibitory factor is related to inflammatory response in coronary bypass surgery using cardiopulmonary bypass,” European Journal of Cardio-thoracic Surgery, vol. 30, no. 1, pp. 59–63, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Simonini, E. Corinaldesi, C. Massai et al., “Macrophage migration inhibitory factor-173 polymorphism and risk of coronary alterations in children with Kawasaki disease,” Clinical and Experimental Rheumatology, vol. 27, no. 6, pp. 1026–1030, 2009. View at Google Scholar · View at Scopus
  29. Y. C. Chen, X. W. Zhang, X. H. Niu et al., “Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer,” Oncogene, vol. 29, no. 21, pp. 3067–3078, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Kleemann and R. Bucala, “Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities,” Mediators of Inflammation, vol. 2010, Article ID 610479, 7 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus